Figure 3: Immunohistochemistry (IHC) and Immunofluorescence (IF) analysis of MD2 expression and immune cell infiltration in prostate cancer tissues. (Upper panel) Representative IF images showing ...

Contemporary analysis of the prognostic significance of intraductal carcinoma of the prostate (IDC-P). Incidence of SREs stratified by no BMA vs BMA treatment.

A multimodal AI model identified a subset of men with very high-risk localized prostate cancer who derived substantial ...

Medically reviewed by Jamin Brahmbhatt, MD Key Takeaways Stage 4 prostate cancer is advanced and has spread beyond the prostate.Hormone therapy is often used to treat stage 4 prostate cancer by ...

Researchers at Baylor College of Medicine and collaborating institutions have developed a method that reveals the cellular makeup of tissues that support metastatic cancer growth, which is the primary ...

Bone metastases represent a common and debilitating stage in the progression of many solid tumours, notably breast, prostate and lung cancers. Tumour cells that home to the skeleton disrupt the normal ...

When androgen receptor (AR) signaling is suppressed, prostate cancer progression is inhibited; however, many patients eventually relapse, developing castration-resistant prostate cancer (CRPC).

There are around 46,000 new cases of prostate cancer each year in England and Wales, with 13% of these cases showing signs of ...

Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trial Radium-223 is an α-emitting ...

Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both before and after surgery for high-risk prostate cancer, significantly ...